Biotech Wrap: VC Disbursements Crawl Through Q1 –

Last year, a virtual stampede of trendy venture capitalists turned to biotech investing as a way to stem the losses being generated by unwise dotcom investments. So far this year, however, it seems that they might have abandoned the biotech bandwagon as well.

According to preliminary data from our